ArticleCureus2026
Fascicular Ventricular Tachycardia: An Electrophysiological Paradox.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a case of fascicular ventricular tachycardia (VT) in a 27-year-old man. Fascicular VT arises within the fascicles of the left bundle of His and is associated with right bundle branch block and axis deviation on ECG. Fascicular VT can often be mislabelled as a narrow-complex tachycardia due to the proximity of the arrhythmic origin to the normal conduction system, creating a widened, but not classically "broad," QRS complex, as occurred in our case. Our patient was resistant to adenosine but sensitive to verapamil, as is characteristic of fascicular VT owing to its origin in a macroscopic reentry circuit within the left bundle of His. Indeed, the patient developed recurrences of fascicular VT whenever verapamil doses were missed. Due to the potential for future hemodynamic instability and myocardial ischemia associated with VT, ablation was considered as a long-term management option for this patient. However, because of his high BMI and the associated theoretical reduction in efficacy, ablation was delayed until the patient achieved weight loss. Further research is needed to determine whether obesity affects ablation outcomes in fascicular VT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.